| Literature DB >> 24700472 |
Yanan Cao1, Minghui He2, Zhibo Gao2, Ying Peng1, Yanli Li1, Lin Li2, Weiwei Zhou1, Xiangchun Li2, Xu Zhong1, Yiming Lei2, Tingwei Su1, Hang Wang2, Yiran Jiang1, Lin Yang2, Wei Wei1, Xu Yang2, Xiuli Jiang1, Li Liu2, Juan He1, Junna Ye1, Qing Wei3, Yingrui Li2, Weiqing Wang4, Jun Wang5, Guang Ning6.
Abstract
Adrenal Cushing's syndrome is caused by excess production of glucocorticoid from adrenocortical tumors and hyperplasias, which leads to metabolic disorders. We performed whole-exome sequencing of 49 blood-tumor pairs and RNA sequencing of 44 tumors from cortisol-producing adrenocortical adenomas (ACAs), adrenocorticotropic hormone-independent macronodular adrenocortical hyperplasias (AIMAHs), and adrenocortical oncocytomas (ADOs). We identified a hotspot in the PRKACA gene with a L205R mutation in 69.2% (27 out of 39) of ACAs and validated in 65.5% of a total of 87 ACAs. Our data revealed that the activating L205R mutation, which locates in the P+1 loop of the protein kinase A (PKA) catalytic subunit, promoted PKA substrate phosphorylation and target gene expression. Moreover, we discovered the recurrently mutated gene DOT1L in AIMAHs and CLASP2 in ADOs. Collectively, these data highlight potentially functional mutated genes in adrenal Cushing's syndrome.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24700472 DOI: 10.1126/science.1249480
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728